APA (7th ed.) Citation

Alkhouri, N., Almomani, A., Le, P., Payne, J. Y., Asaad, I., Polanco, P., . . . Noureddin, M. (2024). The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)-related advanced fibrosis and cirrhosis in the United States population utilizing AGILE 3 + and AGILE 4 scores: Analysis of the NHANES 2017–2018 cycle. BMC gastroenterology, 24(1), 218-7. https://doi.org/10.1186/s12876-024-03295-8

Chicago Style (17th ed.) Citation

Alkhouri, Naim, Ashraf Almomani, Phuc Le, Julia Y. Payne, Imad Asaad, Prido Polanco, Phillip Leff, Prabhat Kumar, and Mazen Noureddin. "The Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)-related Advanced Fibrosis and Cirrhosis in the United States Population Utilizing AGILE 3 + and AGILE 4 Scores: Analysis of the NHANES 2017–2018 Cycle." BMC Gastroenterology 24, no. 1 (2024): 218-7. https://doi.org/10.1186/s12876-024-03295-8.

MLA (9th ed.) Citation

Alkhouri, Naim, et al. "The Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)-related Advanced Fibrosis and Cirrhosis in the United States Population Utilizing AGILE 3 + and AGILE 4 Scores: Analysis of the NHANES 2017–2018 Cycle." BMC Gastroenterology, vol. 24, no. 1, 2024, pp. 218-7, https://doi.org/10.1186/s12876-024-03295-8.